Back

Palisade Bio receives FDA clearance for PALI-2108 Crohn’s disease IND

Verifying
  • Palisade Bio received FDA clearance for the PALI-2108 Crohn’s disease IND.
  • PALI-2108 received clearance for development in Crohn’s disease.
  • Palisade Bio is expanding Phase 2 development across IBD.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.